CORC

浏览/检索结果: 共6条,第1-6条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Preliminary Results from a Phase 1 Study of HMPL-523, a Highly Selective Syk Inhibitor, in Chinese Patients with Mature B-Cell Lymphomas 会议论文
作者:  Zhu, Jun;  Cao, Junning;  Qiu, Lugui;  Qi, Junyuan;  Song, Yuqin
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
Pharmacokinetics of Osimertinib (AZD9291) in Chinese Patients with Advanced NSCLC: A Phase I Study 会议论文
作者:  Cao, Junning;  Chang, Jianhua;  Zhang, Clara;  Leaw, Shiang Jiin;  Wang, Jia
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Elevated High Sensitivity Troponin T (HsTnT) during Front-Line Therapy with Cyclophosphamide, Doxorubicin, Vincristine and Prednisone plus /- Rituximab (CHOP plus /-R) or Cyclophosphamide, Epirubicin, Vincristine and Prednisone plus /- Rituximab (CEpOP plus /-R) Correlates with a Decline in Left Ventricular Ejection Fraction (LVEF) in Patients with Aggressive B-Cell Lymphoma: Results from a Randomized Prospective Clinical Trial NCT00854568 会议论文
作者:  Xue, Kai;  Gu, Juan J.;  Zhang, Qunling;  Liu, Xiaojian;  Wang, Jiachen
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/19
A phase Ib study of VEGFR inhibitor fruquintinib in patients with pretreated advanced colorectal cancer. 会议论文
作者:  Li, Jin;  Cao, Junning;  Xu, Rui-hua;  Chen, Zhiyu;  Zhang, Jian
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
Re-Assessment of the Prognostic Value of International Prognostic Index (IPI) and Revised IPI (R-IPI) in patients with Diffuse Large B-Cell Lymphoma Treated with or without Rituximab in Chinese Populations: A Retrospective Multicenter Study by Shanghai Lymphoma Research Group 会议论文
作者:  Huang, Honghui;  Xiao, Fei;  Chen, Fangyuan;  Wang, Ting;  Li, Junmin
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
Bistable resistance switching of Cu/Ti:ZrO2/Pt for Nonvolatile memory application 会议论文
上海, 0000-00-00 00:00:00
作者:  Shibing Long;  Qi Liu;  Sen Zhang;  Junning Chen;  Ming Liu
收藏  |  浏览/下载:2/0  |  提交时间:2019/04/22


©版权所有 ©2017 CSpace - Powered by CSpace